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Keratinocytes and neurons cells are the main target for Herpes Simplex Virus Type 1 
(HSV-1) invasion. Moreover, keratinocytes are the most abundant cell types in the 
epidermis layer in the skin. Therefore, they are the first cells to encounter HSV-1 in the 
primary infection. Next, the virus reaches the nerve endings and is transferred to neuronal 
cells as a result from the primary infection.  In between these two events, innate immune 
cells including monocytes and macrophages response is activated and recruited to the 
infection site. In this study, keratinocytes (PAM-212) and murine macrophage (RAW 
264.7) cell lines were utilized to investigate the response of macrophages (RAW 264.7 ) 
and keratinocytes (PAM-212) to HSV-1 infection and propagation in vitro. In this study, 
initially keratinocytes (PAM-212) and macrophages (RAW 264.7) and were studied 
either infected or uninfected with HSV-1 at MOI 0.1 in a monolayer model. Cell lines 
were co-cultured at ratio 1:5 (macrophages : keratinocytes) respectively in the co-culture 
model 1. The results showed some differences and similarities in cell viabilities, and viral 
replication between keratinocytes (PAM-212) and macrophages (RAW 264.7) at 24, 48, 
and 72 hours. In both the monolayer and the co-culture model, cells were exhibited 
morphological changes including irregularly shaped or rounded cells, enlargement of cell 
size, and cells appeared in different density compared to neighboring cells especially in 
the earlier phase of infection at 24 and 48 hours.  
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 In contrast, at 72 hours cells were degraded, detached, and more debris was 
observed in the medium. In like manner, our results of cell viability showed some 
variations after 24, 48, and 72 hours which confirms the HSV-1 infection. 
Furthermore, plaque assay showed a significant decrease in HSV-1 titers at 24 hours 
in the co-culture model compared to keratinocytes and macrophages monolayers. 
However, the keratinocyte monolayer appeared to tolerate HSV-1 replication and 
virus titers kept increasing in all time-points.  
On the other hand, the macrophage monolayer exhibited a noticeable decrease in 
the virus concentration at 48 hours, indicating the role of macrophages restricting 
viral replication. The effect of macrophages was diminished as time increased, but 
still exhibited a reduction in the virus titers compared to the keratinocytes and co-
culture at 72 hours. That suggests a pivotal role of macrophages to induce immune 
response that limits viral replication as we proposed in our hypothesis. We still 
believe in the role of the cytokines produced by macrophages such as interferons 







 The hypothesis of this study is that mimicking an in-vivo immune response can be 
induced in a co-culture model as macrophages (RAW 264.7) exposed to keratinocytes 
infected with HSV-1. Macrophages (RAW 264.7) would restrict HSV-1 replication 
within keratinocytes and clear the infection.  
 
   
 
  
     HYPOTHESIS 
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Figure 1: The Structure of Herpes Simplex Virus Type 1 (HSV-1). 
INTRODUCTION 
 Herpes Simplex Virus type 1(HSV-1), is one of the most prevalent human pathogens 
among Herpesviridae family and causes oral and genital herpes infection, ocular 
infection, and encephalitis 2. It infects numerous types of cells, including keratinocytes 
and neurons, which are the main target for a HSV infection. However, the HSV-1 
infection may turn systemic and fatal in young children and immunocompromised people 
3. Moreover, HSV-1 is contributed to 60 – 80% of herpesvirus infections in human 
worldwide and persists for life-long in people who are exposed to the infection 4. The 
HSV-1infection may also induce some symptoms represented in fever, painful vesicles, 
tingling, abnormal sensation, itching, and burning in the lesions occurring in mouth and 
face 5. HSV-1 consists of a linear genome, double-stranded DNA, and envelope that 
carries approximately 13 glycoproteins on the lipid envelope involving in various 





Keratinocytes and HSV-1 Entry:  
 Skin is a very important natural defense barrier to protect the body from external 
environments 7. It is composed of two main layers: dermis and epidermis. The dermis 
layer is rich in nerves and blood vessels while the epidermis layer consists of different 
cell types including melanocytes, Langerhans cells, and Merkel cells, but keratinocytes 
are the major resident in the epidermis in the skin 8. Oral mucosa has a similar structure 
to the skin and rich in keratinocytes 9. More importantly, it has been found that 
keratinocytes can produce cytokines, that drives immune response, as well as many other 
growth factors which are all essential for maintaining the natural homeostasis 10.  What 
we mean to say is that keratinocytes have a pivotal role playing as a physical barrier and 
immune response inducer against invaders.    
When Herpes Simplex Virus Type 1(HSV-1) encounters the host cell, it may utilize both 
endocytosis and fusion within the plasma membrane pathways by binding to the HveC 
gD receptor which is also known as nectin-1; suppression of this receptor leads to 
reduction of the HSV-1 entry on murine keratinocytes 11. The importance of the nectin-1 
receptor that mediates the HSV-1 entry has been reported in many studies.  The 
glycoprotein D (gD) facilitates the HSV-1 entry by interacting with the nectin-1 receptor 
on the host cells 12. In addition to the nectin-1 receptor, there are many receptors 
involving virus entry into a host cell, including herpesvirus entry mediator (HVEM) and 





The Role of Macrophages During HSV-1 Infection:  
Macrophages are derived from monocytes, and they play important roles in regulating the 
innate immune response during inflammation and infection.  Hence, macrophages present 
and emigrate within the bloodstream, and some of them reside in tissues 13. During infection, 
macrophages play critical roles in homeostasis, tissue repair, and inducing immune response. 
Thus, macrophages are found almost all over the body, and they act as phagocytic cells 
which engulf and kill invaders and foreign substances 14. While in the HSV-1infection, the 
virus binds to macrophage utilizing the toll-like receptor (TLR) and activates the myeloid 
differentiation primary response 88 (MyD88) signaling the pathway leading to the production 
of pro-inflammatory cytokines such as anti-viral interferon; in addition, macrophages can 
eliminate the HSV-1 infection in various ways that includes the production of reactive 
oxygen species (ROS) and nitric oxide (NO) 15. 
 
In this study, the PAM-212 murine keratinocytes and RAW 264.7 macrophage cell line 
were selected for studying the role of macrophages in restricting HSV- 1 replication during 
infections. The hypothesis of this study was that mimicking the in-vivo immune response 
will be induced by macrophage when keratinocytes is infected with HSV-1. The effects of 
HSV-1 on cell viability, morphology, and replication at 24, 48, and 72 hours were observed 
in each cell types and in co-culture. The RAW 264.7 macrophage cell line would restrict 









Figure 2: This Diagram Illustrates the Main Layers of the Skin. The 
epidermis layer is the first layer in the skin and it is composed of several 
layers and different types of cells, mainly keratinocytes. The dermis layer is 














Figure 3: The Two Different Pathways for Herpes Simplex Virus Type 1 Entry 
into the Host Cell: by Direct Fusion within the Plasma Membrane or by the 
Endocytosis pathway.   
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LITERATURE REVIEW  
 
Herpes Simplex Virus Type 1  
The word herpes was taken from Greek ancient language meaning crawl or 
creep; after that herpes viruses family was named including Herpes Simplex Virus 
Type 1 (HSV-1) and Herpes Simplex Virus Type 2 (HSV-2) which are the most 
contagious pathogens in humans 16. Herpes Simplex Virus Type 1 (HSV-1) belongs 
to the alphaherpesvirus subfamily, and the virion composed of four main parts 
including dsDNA genome (157 kb), teguments, nucleocapsid, and glycoproteins on 
the surface of the envelope 17.  However, it is known to infect humans and cause 
infectious diseases including orofacial and genital herpes 18.  
HSV-1 infection is often present in tissues that are enriched in keratinocytes 
and nerve endings as a main target to initiate the infection. Therefore, skin, the 
mucosa, and the cornea are the primary entry site for the HSV-1 infection in humans 
19. In general, the virus develops two types of infection post the inoculation: primary 
and latent infection. Following the primary infection that occurred in the epithelial 
cells, the virus undergoes a latency state in ganglion cells and persists for lifelong in 
the victim 20.  Unfortunately, there is no treatment or vaccine that could prevent 







Herpes Simplex Virus Type 1 Entry and Infection in Keratinocytes: 
HSV-1 utilizes different pathways to target the host cell either by fusion with 
the plasma membrane directly or by endocytosis, either pH-dependent or pH-
independent 22.  The infection starts when the virus encounters the skin or the mucosa 
and establishes binding between viral glycoproteins on the envelope and a specific 
type of cellular receptors to invade targeted cells on the epithelium 23. The common 
receptors on the surface of the host cell that trigger HSV-1 entry are nectin-1, herpes 
virus entry mediator HVEM, heparan sulfate (HS), and 3-O-HS. By contrast the 
nectin-1 and HVEM have been reported as most involved in HSV infections and 
pathogenesis among humans 24.   
The event of entry is initiated by binding the viral glycoproteins gB and gC to 
heparan sulfates (HS) and paired immunoglobulin-like type 2 receptor alpha (PILRα) 
on the surface of the host cell which leads gD binding to nectin-1 or HVEM and 
induces conformational changes on gH/gL followed by nucleocapsid  fusion within 
the host cell plasma membrane to the cytoplasm 25. Thus, the tegument proteins that 
protect the nucleocapsid, dissociate and translocate the viral genome into the nucleus 
of the host cell, and establish viral immediate-early transcription 26.  First, the viral 
immediate-early genes transcription and translation includes IE, α, E, and β followed 
by viral DNA replication. Then, it binds to infected cell protein 8 (ICP8) which 
activates the transcription and the translation of the late genes (L&γ) that were 
encoded for the nucleocapsid and the teguments. Eventually, the viral genome will be 
packaged in the nucleocapsid and released from the host cell 27-28. Hence, the new 
virion is ready to invade other host cells. 
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In a study, it has been confirmed that the pro-inflammatory cytokine INF-β 
was produced in the infected epidermis keratinocytes with HSV-1 in both cell culture 
and specimens were taken from human patients 29.  In contrast, other study suggested 
that cell immune response is inhibited when viral genes are expressed that indicates 
the role of viral genes to inhibit antiviral response 30.  As an example, during the early 
phase of the infection, ICP0 is expressed and that may activate viral gene expression 
and inhibit type 1 IFN-gene induction resulting in augmentation of infection 31-32. In 
addition, ICP0 expression may degrade interferon inducible protein-16 (IFI-16) and 

















 The Role of Innate Immune System During HSV-1 Infection: 
The immune system is the first line of defense in the body against pathogens 
and foreign substances. There are many types of immune cells involved in this duty 
including natural killer (NK), dendritic cells (DC), neutrophils, and macrophages; 
however, all these cell types participate in restricting HSV-1 invasion. Moreover, T 
lymphocytes including both CD4+ and CD8+ are important to produce type 1 IFN for 
inhibiting the HSV-1 infection and replication 33. In contrast, HSV-1 has multiple 
pathways to impair anti-viral productions such as interfering with IFN expressions 
and functions 34.  
However, the macrophages are immune cells derived from monocytes that 
originated from the bone marrow and migrate through the blood stream 35.   
Eventually, they reside in different tissues and have different names. Hence, they play 
pivotal roles to protect the body from pathogens, to maintain homeostasis, to involve 
in damage repair, and to engulf foreign substances. Furthermore, these immune cells 
induce immune responses by secreting pro-inflammatory cytokines, chemokines, and 
tumor necrosis factors 36. Thus, macrophages sense the danger signals via Toll-like 
receptors (TLRs), pattern recognition receptor (PRRs), and interleukin-1 receptor (IL-
1R) and establish the MyD88 signaling pathway 13.  This binding results in pro-







Herpes Simplex Virus Type 1 (HSV-1) immune evasion strategies  
The HSV-1 has multiple mechanisms to escape immune recognition and 
maintain virus replication by inhibiting innate immune cells and epithelial cells of 
immediate immune response soon after invasion as well as inhibiting cellular 
translation and programed cell death 37.  Moreover, it can interfere with the major 
histocompatibility complex class 1 (MHC I), complement activation, down-regulate 
Fc receptor, and prevent apoptosis in host cell; in addition, the HSV-1 has the ability 
to inhibit MHC II expression on macrophages which leads to a reduction of cytokines 
production by natural killer cells (NK) and T lymphocytes 38.   
Likewise, the HSV-1 infected keratinocytes inhibit the pro-inflammatory 
cytokines such as interleukin-1β (IL-1β), and block interferon IFNs’ functions 34.  By 
contrast HSV-1 infected keratinocytes continue to produce the interleukin-1α (IL-1α) 
which is important for recruiting white blood cells to the site of infection and 
preventing viral replication. The IL-1β shows high expression in macrophages; 
however, both of IL-1α and IL-1β have same cellular receptor which is IL-1 receptor 
type 1(IL-1R) 39. The role of IL-1α has been demonstrated for immune cells 
recruitment by blocking IL-1R which lead to a significant decrease in neutrophil 








MATERIALS AND METHODS 
Three different cell lines and (HSV-1) virion were utilized on two models of cell 
culture (monolayer and co-culture system) in this study. 
PAM212 is a keratinocyte cell line derived from newborn BALB/c mice and was 
previously obtained from Joanna Anders at NIH/NCI. The RAW 264.7 murine 
macrophage cell line is derived from a tumor induced by Abelson murine leukemia virus 
obtained from an adult male BALB/c mouse. Both are adherent cell lines by nature. They 
were initially thawed and seeded individually in T-25 (25 cm2) culture flasks, and then 
transferred to T-75 (75 cm2) culture flasks for maintenance and cell splitting.  
Each monolayer was grown in the presence of Dulbecco's Modified Eagle Medium 
(DMEM) (Fisher Science, Pittsburgh, PA) supplemented with 10% heat inactivated fetal 
bovine serum (FBS).  
HSV-1 (syn17+) (initially provided by Dr. Nancy Sawtell, Children’s Hospital 
Medical Center, Cincinnati, OH), was utilized for infection. Prior to infection, a Plaque 
Assay was performed to determine the virus titers in the original stock by utilizing Vero 
cells line (CCL-81, American Type Culture Collection) developed from African green 
monkey kidney epithelial cells. The PFU/ml for the virus in original stock was 6.8 X 107 
viral particles per ml. Therefore, 0.44 µl or 0.22 µl of virus stock was added to 1000 µl 
media supplemented with 1% FBS per well for infection. In this study, 6-well plates were 
used for the cell infection and the Plaque Assay throughout the experiments. Cell cultures 





Infection Protocol for Keratinocytes (PAM-212): 
The keratinocytes (PAM-212) were seeded in 6-well plates at density of 3 X 
105 cells per well. Each well was supplied with 3 ml medium containing 10 % FBS 
and incubated overnight for cell adhesion. At 70% of cell confluence, old medium 
was discarded and washed with 2 ml of PBS prior infection. In each well, 1 ml of a 
new medium supplemented with 1% FBS was added. Hence, a volume of 0.44 µl was 
taken from the (HSV-1) original stock to infect three wells at multiplicity of infection 
(MOI) 0.1 ratio 1:10 while the remaining three uninfected wells were used as a 
negative control. Then cell cultures were incubated for 2 hours to establish the 
infection. In the next step, the virus was removed, cell cultures were washed with 2 
ml of PBS per well, and 3 ml of fresh medium supplemented with 10% FBS was 
added. Again, cell cultures were incubated at 37 Co and 5% Co2 for 24, 48, and 72 
hours after the infection. After the incubation period, the suspension was collected 
from the 6-well plates individually in 15 ml centrifuge tubes and centrifuged at 1600 
(rpm); 4 Co for 5 minutes. 1000 µl of the supernatant from each tube was transferred 
to the 1.5 ml centrifuge tubes and stored at – 80 Co for plaque assay. The 15 ml 
centrifuge tubes that were used previously were reused to collect cells after 
trypsinization and centrifuged at 1600 (rpm); 4 Co for 5 minutes to form a pallet in the 
bottom of the tubes. The supernatant obtained after trypsinization was aspirated, and 






Infection Protocol for Unpolarized Macrophages (RAW 264.7): 
Unpolarized macrophages (RAW 264.7/ M0) were seeded in 6-well plates at density 
of 3 X 105 cells per well. 3 ml of media supplemented with 10 % FBS was added to each 
well and incubated for cell attachment. After cell adhesion, old medium was removed and 
washed with 2 ml of PBS prior infection. In each well, 1 ml of a new medium 
supplemented with 1% FBS was added. After that, a volume of 0.44 µl was taken from 
the (HSV-1) original stock to infect three wells at multiplicity of infection (MOI) 0.1 
ratio 1:10 while the remaining three uninfected wells used as a negative control. Then the 
plates were incubated for 2 hours to establish the infection. In the following step, the 
virus was removed, cell cultures were washed twice with 2 ml of PBS, and 3 ml of fresh 
medium contained 10% FBS was added. After that, cell cultures were incubated at 37 Co 
and 5% Co2 for 24, 48, and 72 hours post-infection. Following the incubation time, cells 
were detached form 6-well plates by utilizing cell scraper (Thermo-Fisher Scientific 
Brand). The suspension was collected from each well individually in 15 ml centrifuge 
tubes and centrifuged at 1600 (rpm); 4 Co for 5 minutes. 1000 µl of each supernatant was 
transferred to the 1.5 ml Eppendorf tubes and stored at – 80 Co for plaque assay. The 
pellet in the bottom of the tubes remained intact when the supernatant was taken. The 
remaining of supernatant was aspirated, and the pellet was resuspended in 1 ml of 10% 







 Infection Protocol for Co-culture (PAM-212& RAW 264.7): 
First, keratinocytes (PAM-212) were seeded in 6-well plates at density of 1.5 X 
105 cells per well. Each well was supplied with 3 ml medium containing 10 % FBS 
and incubated overnight for cell adhesion. After cell adhesion, old medium was 
removed and washed with 2 ml of PBS prior infection. In each well, 1 ml of a new 
medium supplemented with 1% FBS was added. After that, a volume of 0.22 µl was 
taken from the (HSV-1) original stock to infect three wells at multiplicity of infection 
(MOI) 0.1 ratio 1:10 while the remaining three uninfected wells were used as a 
negative control. Then the plates were incubated for 2 hours to initiate cell infection. 
In the following step, the virus was removed, cell cultures were washed with 2 ml of 
PBS, and 3 ml of fresh media containing 10% FBS was added. Second, unpolarized 
macrophages were added at ratio 1:5 of keratinocytes 1. Thus 3 X 104 cells of M0 
macrophages (RAW264.7) were added to the 1.5 X 105 cells of keratinocytes (PAM-
212) previously seeded and infected with HSV-1 in 6-well plates. After that, cell 
cultures were incubated at 37 Co and 5% CO2 for 24, 48, and 72 hours post-infection. 
Following the incubation period, the suspension was collected from each well 
individually in 15 ml centrifuge tubes and centrifuged at 1600 (rpm); 4 Co for 5 
minutes. 1000 µl of the supernatant of each was transferred to the 1.5 ml Eppendorf 
tubes and stored at – 80 o C for plaque assay. The 15 ml centrifuge tubes that were 
used previously, were reused again to collect cells after trypsinization and centrifuged 
at 1600 (rpm); 4 Co for 5 minutes to form a pallet in the bottom of the tubes. The 
supernatant obtained after trypsinization was aspirated, and the pellet was 
resuspended in 1 ml of 10% FBS media for calculating the cell viability. 
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      Cell Viability:  
Trypan Blue Exclusion Test was used to determine the cell viability which indicates 
the percentages of viable and non-viable cells in the suspension obtained from cell 
culture. It requires a sample of suspension, hemocytometer, trypan blue stain (Fisher 
Scientific, Pittsburgh, PA brand), coverslips, micropipettes (P1000, P200, and P20), blue 
and yellow tips, and light microscope. First, the sample of suspension was obtained by 
scraping and/or trypsinization as described previously.  The suspension was collected in 
15 ml centrifuge tubes and centrifuged at 1600 (rpm); 4 Co for 5 minutes to form a pellet 
in the bottom of the tubes. The supernatant was aspirated, and the pellet was resuspended 
in 1 ml of 10% FBS media. Second, cells were mixed well utilizing a micropipette 
(P1000). Then, 100 µl of trypan blue stain and 50 µl of the suspension were transferred 
via micropipette (P200) to 1.5 ml Eppendorf tube and mixed genially. Third, 10 µl was 
taken by micropipette (P20) form the blend and placed on the hemocytometer initially 
covered with coverslip. Fourth, the hemocytometer was examined under the 10x 
magnification power in the light microscope. Finally, cells were counted, viable cells 





















Figure 4: Trypan Blue Exclusion Test utilizing hemocytometer.  
Under the light microscope lens at 10x magnification power, cells were counted. Each 
circular dot represents cell. The bright dots represent viable cells while the dark once 




The plaque assay measures infectious virus particles contained in a stock. Thus, 
plaque formation means the virus was able to initiate infection, propagate and display 
cytopathic effect (CPF) on cell culture.  The plaques can be counted and visualized by the 
naked eye after staining the plate with 1% of crystal violet as colorless spots. Therefore, 
virus titers were calculated based on the plaque forming units per ml (PFU/ml).  
Herpes Simplex Virus-1 strain Syn 17+ was previously obtained from (Dr. Nancy 
Sawtell, Children’s Hospital Medical Center, Cincinnati, OH). Prior to utilizing HSV in 
this study for infection, virus titers were determined. Plaque assay was performed on 
Vero cells at 100% confluency. Initially, Vero cells were seeded in 6-well plates at 
density of 3 X 105 cells per well. 3 ml of media supplemented with 10 % FBS was added 
to each well. Vero cells usually reach 100% confluency within 2-3 days.  Before 
infection, a serial dilution for original stock is required (Figure 4). First, 10 - 1.5 ml 
centrifuge tubes were set on a rack and labeled from -1 to -10 as a dilution factor. Then 
900 µl of DMEM without FBS was added to each tube. A 100 µl of virus stock was 
transferred to the first tube. Next, 100 µl was taken from tube -1 to tube -2, this process 
continued to the last tube -10.  After that, old medium was removed from Vero cells 
culture and washed with 2 ml of PBS prior infection. To infect cells, 500 µl of diluted 
virus was added to each well. The first well of 6-well plates was used as a negative 
control. Then, the plates were incubated for 1 hour to establish the infection. In the 
following step, the virus was removed, cell cultures were washed once with 2 ml of PBS 
and covered with 3 ml of 4% methyl-cellulose. Next, plates were incubated at 37 Co and 
5% Co2. The plaques were usually seen after 3-5 days. After the plaques were formed, 3 
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ml of 4% paraformaldehyde was added for fixation. Plates were incubated at room 
temperature for 1 hour. Then agarose and paraformaldehyde were removed and washed 
gently with tap water. About 2 ml of 1% crystal violet solution (Sigma) was added and 
incubated at room temperature for 5-10 minutes. Stain was removed with tap water, and 
plaques were counted as followed.   
PFU/ml (of original stock) = 
number of plaques















Figure 5: Serial Dilution Method for Plaque Assay.   
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       Statistical Analysis  
Data were obtained from conducting triplicates within all experiments in this 
study. Sigma-Plot 12.0 software; One-Way ANOVA, was utilized for analyzing data 
and calculating statistical significance. Outcomes were compared for the P-values, 
any data showing ≤ 0.05 were considered as statistically significant.  
 
Symbol Meaning 
ns P > 0.05 
* P ≤ 0.05 
** P ≤ 0.01 
*** P ≤ 0.001 






The Cell Viability of Uninfected and Infected Keratinocytes (PAM-212) with HSV-
1 after 24, 48, and 72 Hours. 
Keratinocytes were either uninfected (control) or infected with herpes simplex 
virus type 1 at multiplicity of infection (MOI) 0.1. Cell viability was determined after 
24, 48, 72 hours by performing Trypan Blue Exclusion Test. In all experiments 
exhibited significant decrease in cell viability at 24, 48, and 72 hours post infection. 
Keratinocytes exhibited slightly significant decrease (~6.5%, P-value = 0.001) in cell 
viability following infection with HSV-1 compared to control at 24 hours. Also, a 
significant decrease in viability was observed in keratinocytes (~16.6%, P-value = < 
0.001) following infection at 48 hours. However, after 72 hours of infection there was 
a strongly significant decrease in cell viability about (~46.7%, P-value = <0.001). In 
contrast, there was no significant difference between in infected keratinocytes at 24 
and 48 hours (P-value = 0.055). In contrast, keratinocytes infected with HSV-1 at 72 
hours showed significant decrease in cell viability compared to 24 and 48 hours (P-








The Cell Viability of Uninfected and Infected Macrophages (RAW 264.7) with 
HSV-1 after 24, 48, and 72 Hours. 
Macrophages were either uninfected (control) or infected with herpes simplex 
virus type 1 at multiplicity of infection (MOI) 0.1. Cell viability was counted after 24, 
48, and 72 hours by utilizing Trypan Blue Exclusion Test. There was no statistically 
significant difference in cell viability at 24 post infection (~1%, P-value = 0.439). At 
48 and 72 hours following infection, macrophages exhibited a large significant 
decrease in cell viability (~8.1%, 46.3%, P-value = <0.001, P-value = <0.001), 
respectively, compared to control. There was significant difference between infected 
macrophages at 24 and 48 hours (~5.3 %, P-value = 0.033). In contrast, at 72 hours 
macrophages infected with HSV-1 showed significant decrease in cell viability 
compared to 24 and 48 hours (~44.8%, ~39.5%, P-value = <0.001, P-value = <0.001) 










The Cell Viability of Uninfected and Infected Co-culture (RAW 264.7 & PAM-212) 
with HSV-1 after 24, 48, and 72 Hours. 
In the co-culture model, keratinocytes were first either infected with HSV-1 or 
uninfected as a negative control at multiplicity of infection (MOI) 0.1 and incubated 
for 2 hours, then the macrophages were added at ratio of 1:5 and incubated for time-
points. Cell viability was examined after 24, 48, and 72 hours by utilizing Trypan Blue 
Exclusion Test. They exhibited a slightly significant difference in cell viability at 24 
post infection (~1% (*) P-value = 0.026). While at 48 and 72 hours following infection, 
co-cultured cell lines exhibited a large significant decrease in cell viability (~36.3%, 
64.6%, P-value = <0.001, P-value = <0.001), respectively compared to the control. 
However; in comparison to the different of time-points, there was a significant 
difference between infected co-cultured cell lines at 24, 48 and 72 hours (P-value = 












The Cell Viability compared between all Cell Lines (RAW 264.7, PAM-212, and 
Co-culture) Uninfected and Infected with HSV-1 after 24 Hours. 
The cell viability was tested for all cell lines (RAW 264.7/M0 & PAM-212) in 
monolayers and co-culture model, after they were infected with herpes simplex virus 
type 1 at multiplicity of infection (MOI) 0.1 and incubation time for 24 hours. The 
cell lines were either infected with HSV-1 or uninfected as a negative control. Cell 
viability was examined after 24 hours by utilizing Trypan Blue Exclusion Test. The 
keratinocytes (PAM-212) monolayer exhibited a significant reduction in cell viability 
at 24 post infection (~6.5%, P-value = 0.001). The macrophage (RAW 264.7) 
monolayer showed no significant difference at 24 hours following infection. By 
contrast the co-cultured cell lines exhibited a little significant decrease in cell viability 
(~1%, P-value = 0.026) compared to the control. However, in comparison between 
the co-cultured cell lines versus the different monolayers cell line, it showed a 
significant increase in cell viability at 24 hours (~7.7%, 7.5%; P-value = <0.001, P-
value = <0.001) respectively.  There was no significant difference between the 










The Cell Viability compared between all Cell Lines (RAW 264.7/M0, PAM-212, 
and Co-culture) Uninfected and Infected with HSV-1 after 48 Hours. 
The cell viability was tested for all cell lines (RAW 264.7/M0 & PAM-212) in 
monolayers and co-culture model, after they were infected with herpes simplex virus 
type 1 at multiplicity of infection (MOI) 0.1 and incubated for 48 hours. The cell lines 
were either infected with HSV-1 or uninfected as a negative control. Cell viability 
was examined after 48 hours by utilizing Trypan Blue Exclusion Test. All monolayers 
and co-cultured cell lines (PAM-212, RAW 264.7/M0, and Co-culture) exhibited a 
significant decrease in cell viability at 48 post infection (~16.6%, 8.1%, & 36.3%; P-
value = <0.001 P-value = <0.001, P-value = <0.001) respectively were compared to 
control. However; in comparison between the different of cell lines, there was no 
significant difference between the keratinocyte and macrophage monolayers infected 
groups (~5.1 %,  P-value = 0.282) while the co-cultured cell lines infected group 
showed a great significant decrease in cell viability at 48 hours (~19 %, 24.1%; P-
value = <0.001, P-value = <0.001) compared to (PAM-212 & RAW 264.7/M0) 









The Cell Viability compared between all Cell Lines (RAW 264.7, PAM-212, and 
Co-culture) Uninfected and Infected with HSV-1 after 72 Hours. 
The cell viability was tested for all cell lines (RAW 264.7/M0 & PAM-212) in 
monolayers and co-culture model, after they were infected with herpes simplex virus 
type 1 at multiplicity of infection (MOI) 0.1 and incubated for 72 hours. The cell lines 
were either infected with HSV-1 or uninfected as a negative control. Cell viability 
was examined after 72 hours by utilizing Trypan Blue Exclusion Test. All monolayers 
and co-cultured cell lines (PAM-212, RAW 264.7/M0, and Co-culture) exhibited a 
great significant decrease in cell viability at 72 post infection (~46.7%, 46.3%, & 
64.6%; P-value = <0.001 P-value = <0.001, P-value = <0.001) respectively. However, 
there was no significant difference between the keratinocytes and macrophages M0 
monolayers infected groups (~6.1%, P-value = 0.323) while the co-cultured cell lines 
infected group showed a great significant decrease in cell viability at 72 hours (~26.7 
%, 20.6%; P-value = <0.001, P-value = 0.003) compared to (PAM-212 & RAW 











Herpes Simplex Virus Type1 Cytopathic Effect (CPE): 
All cell lines (PAM-212, RAW 264.7, and co-culture) were seeded, maintained, 
and infected on 6-well plates. In each plate, three wells were infected with HSV-1 and 
the three remaining were used as a negative control. Post-infection, plates were 
incubated at 37Co, 5% Co2, for 24, 48, and 72 hours. The HSV-1 cytopathic effect 
(CPE) was evident in all infected groups during incubation time-points.  After 24 
hours of infection, some of cells appeared enlarged in size, irregularly shaped, and 
some were floating in the medium, that indicates cell lysis and HSV-1 cytopathic 
effect. At 48 post-infection, same signs were observed, but in higher percentages. 
Furthermore, at 72 hours post-infection cell were mostly detached and more debris 
were visible. The HSV-1 cytopathic effect (CPE) on Vero cell was clear prior to 














Plaque Assay:  
Plaque assay was utilized to calculate HSV-1 concentrations in different samples 
were collected from different experiments and stored at – 80 Co. Therefore, Plaque 
assay was performed in triplicate on 6-well plates, and each single assay represents 
different samples within experiment. The supernatant that used for plaque assay was 
obtained from keratinocytes (PAM-212), macrophages (M0), and (PAM-212 and M0) 
co-cultured cell lines post-infected them with HSV-1 at 24, 48, and 72 hours. Plaques 
formation were evident at different serial dilution factors (SDFs) from 10-1 to 10-10.  
 
The Plaque Assay for Keratinocytes (PAM-212) Infected with HSV-1 at 24, 48, and 
72 Hours. 
In keratinocytes (PAM-212) at 24 hours, plaques formation was observed from 
10-1 to 10-5. However, the virus titers were counted at x10-3, and the plaque formed 
per ml (PFU/ml) was 12.6 X 10-3 in average. At 48 hours, plaques formation was 
observed from 10-1 to 10-10. The virus titers were counted at x10-8, and the plaque 
formed per ml (PFU/ml) was 214 X 10-8 in average. While at 72 hours, plaques 
formation was observed from 10-1 to 10-10. The virus titers were counted at x10-8, and 
the plaque formed per ml (PFU/ml) was 224 X 10-8 in average. On the other hand, 
HSV-1 titers were significantly increased in the keratinocytes from 24 to 48 and 72 
hours respectively. In contrast, there was no significant difference between virion 





The Plaque Assay for Macrophages (RAW 264.7 / M0) Infected with HSV-1 at 24, 
48, and 72 Hours. 
In macrophages (RAW 264.7/ M0) at 24 hours, plaque formation was observed 
from 10-1 to 10-5. However, the virus titers were counted at x10-3, and the plaque 
formed per ml (PFU/ml) was 65.6 X 10-3 in average. At 48 hours, plaques formation 
was only observed from 10-1 to 10-5 and there were no plaques formation beyond the 
dilution factor x10-5 as was demonstrated by six trials. The virus titers were counted 
at x10-2, and the plaque formed per ml (PFU/ml) was 132 X 10-2 in average. While at 
72 hours, plaques formation was observed from 10-1 to 10-10. The virus titers were 
counted at x10-8, and the plaque formed per ml (PFU/ml) was 91 X 10-8 in average. 
Moreover, HSV-1 titers were remarkably decreased in the macrophages from 24 to 48 
hours. However, there was a large significant increase in virion titers at 72 hours 












The Plaque Assay for Co-culture (PAM-212 + M0) Infected with HSV-1 at 24, 48, 
and 72 Hours. 
In co-culture model (PAM-212 + RAW 264.7/M0) at 24 hours, plaque formation 
was observed only at 10-1 in one plate while other plate did not show any plaque 
formation beyond the dilution factor x10-1 as was demonstrated by four trials. 
However, the virus titers were counted at x10-1, and the plaque formed per ml 
(PFU/ml) was 55.3 X 10-1 in average. At 48 hours, plaque formation was observed 
from 10-1 to 10-10. The virus titers were counted at x10-8, and the plaque formed per 
ml (PFU/ml) was 34.6 X 10-8 in average. While at 72 hours, plaques formation was 
observed from 10-1 to 10-10. The virus titers were counted at x10-8, and the plaque 
formed per ml (PFU/ml) was 91.3 X 10-8 in average. However, HSV-1 titers were 
noticeably decreased in the co-culture model at 24 compared to virus titers at 48 and 
72 hours respectively. Nevertheless, there was a slight difference between virion 























Co-culture Model  
(PAM-212 + RAW 264.7) 
PFU/ml 
24 Hours 12.6 X 10-3 65.6 X 10-3 55.3 X 10-1 
48 Hours 214 X 10-8 132 X 10-2 34.6 X 10-8 












Table 2: This table illustrates Plaque Forming Units Per ml (PFU/ml) for Herpes Simplex 
Virus Type 1 Obtained by Plaque Assay.  
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The Plaque Assay compared between all Cell Lines (RAW 264.7, PAM-212, and 
Co-culture) Infected with HSV-1 after 24 Hours. 
The plaque assay was performed for all the infected cell lines (RAW 264.7/M0 & 
PAM-212) in monolayers and co-culture model. Then, the HSV-1 titers were 
compared for 24 hours. The keratinocytes (PAM-212) monolayer exhibited less 
significant virus concentration compared with macrophages at 24 hours (~5.1fold, P-
value = <0.001). The macrophage (RAW 264.7 /M0) monolayer showed the most 
significant increase in HSV-1 replication at 24 hours compared to keratinocytes and 
co-culture (~5.1 fold, 118 fold, P-value = <0.001, P-value = <0.001) respectively. On 
the other hand, the co-cultured cell lines (PAM-212 + RAW 264.7/M0) exhibited the 
lowest significant in virion titers compared to the monolayers infected groups at 24 














The Plaque Assay compared between all Cell Lines (RAW 264.7, PAM-212, and 
Co-culture) Infected with HSV-1 after 48 Hours. 
The plaque assay was performed for all the infected cell lines (RAW 264.7/M0 & 
PAM-212) in monolayers and co-culture model. Then, the HSV-1 titers were 
compared for 48 hours. The keratinocytes (PAM-212) monolayer exhibited no 
significant in virus concentration compared with co-culture at 48 hours (~1.5 fold, P-
value = 0.078). While the macrophages (RAW 264.7 /M0) monolayer showed the 
lowest significant in HSV-1 replication at 48 hours compared to keratinocytes and co-
culture (~1.65X106 fold, 1.11X106 fold, P-value = 0.008, P-value = 0.012) 
respectively (Figure 17).  
 
The Plaque Assay compared between all Cell Lines (RAW 264.7, PAM-212, and 
Co-culture) Infected with HSV-1 after 72 Hours. 
The plaque assay was performed for all the infected cell lines (RAW 264.7/M0 & 
PAM-212) in monolayers and co-culture model. Then, the HSV-1 titers were 
compared for 72 hours. The keratinocytes (PAM-212) monolayer exhibited a 
significant increase in virus concentration compared with macrophages (M0) and co-
culture at 72 hours (~5.6 fold, 2.44 fold, P-value = <0.001, P-value = <0.001). While 
the macrophages (RAW 264.7 /M0) monolayer showed the less significant in HSV-1 
replication at 72 hours compared to keratinocytes and co-culture (~5.6 fold, 2.3 fold, 






The goal of this study was to develop a new model of cell co-culture that 
could illustrate the role of the macrophages (RAW 264.7) in responding to Herpes 
Simplex Virus Type 1 (HSV-1) within infected keratinocytes. For this purpose, we 
used macrophages (RAW 264.7) and murine keratinocytes (PAM-212) to investigate 
the susceptibility of each cell line in monolayer to the HSV-1 infection. In the next 
step, we started to infect the keratinocytes with HSV-1 for two hours at the 
multiplicity of infection (MOI) 0.1. Then the virus was removed, and the cell culture 
was washed with PBS prior to co-culturing them with the macrophages at ratio “1:5” 
1 for time-points of 24, 48, and 72 hours. In this study, we just focused on the 
cytopathic effect (CPE), cell viability, and plaque assay.   
Interestingly, we found that there were some differences and similarities 
between keratinocytes (PAM-212) and macrophages (RAW 264.7) in all the models 
that we used in this study. We observed some morphology changes that were a result 
of the HSV-1 invasion to the host cells after 24, 48, and 72 hours. These morphology 
changes illustrate the cytopathic effects (CPE) of the HSV-1 infection. However, the 
different cell lines that we utilized in this project exhibited almost the same 
morphology changes in the earlier phase of the infection at 24 and 48 hours. The 
infected cells appeared either irregularly shaped or rounded cells, enlarged in size, 
and seemed in different density compared to the surrounding area. In contrast, at 72 
hours cells were degraded and detached, and there was more debris in the medium in 
the keratinocytes monolayer. The macrophage monolayers and the co-culture were 
similar to keratinocytes except the medium was clearer with less debris (Figure 12). 
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We attributed the clearance of debris in the medium to the macrophages’ ability to 
engulf and digest the foreign substance. Same signs of cytopathic effects have been 
observed in vitro on the infected epithelium and described as “a reticular degeneration 
and ballooning of the cells as well as the appearance of large irregular or 
multinucleated giant cells” 41-42.  
Our results suggest that the PAM-212 and RAW 264.7 cell lines were 
susceptible to the HSV-1 infection and replication within the observation time-points 
of 24, 48, and 72 hours. In spite of the fact that macrophages are more likely to play 
pivotal role in preventing the HSV-1 infection, they were found also to be susceptible 
to the virus replication 35.  
The results of the cell viabilities were significantly decreased in the 
keratinocytes PAM-212 monolayer infected with HSV-1 at 24 hours, while the 
infected macrophages showed no significant difference in cell viability at 24 hours 
post-infection. That shows both PAM-212 and RAW 264.7 susceptible to the virion. 
On the other hand, in the co-culture model there was a noticeable increase in cell 
viability of the PAM-212 keratinocytes at 24 hours. Since the macrophages were 
added two hours later to the infected PAM-212, they response to the stimuli produced 
from the infected keratinocytes. That suggests the role of macrophages in preventing 
pathogens invasion in the body and in the co-culture model.  
Surprisingly, at 24 hours post-infection our results of the plaque assay show a 
significant increase in the virus concentration (~5.1 fold, P-value = <0.001) in the 
macrophages supernatant compared to the PAM-212 which exhibited less virus titers 
35 
 
that suggests the ability of HSV-1 to suppress the immune response at an early phase 
of the infection (Figure 16). These results are in agreement to what has been reported 
in the ability of the HSV-1 to manipulate the immune invasion strategies to maintain 
virus replication in epithelial cells and innate immune cells 37.  
In our co-culture model, we assumed that the role of macrophages that restrict 
HSV-1 dissemination. Our results demonstrate a remarkable decrease in the virus 
PFU/ml in this model at the first 24 hours compared to the keratinocytes and the 
macrophages monolayers (~22.7 fold, 118 fold, P-value = <0.001, P-value = <0.001) 
respectively (Figure 16). Therefore, we attribute that to the immune response of RAW 
264.7 macrophages to virus released from the keratinocytes infected with the HSV-1 
two hours prior to the addition of macrophages at ratio 1:5 (macrophages : 
keratinocytes). Thus, we think that the cytokines which were produced from infected 
cells such as INF-α/β, IL-1α, TNF, and reactive oxygen species (ROS) activate the 
macrophage and guide them toward the site of infection. Moreover, it has been 
reported that the interleukin-1β was inhibited by the HSV-1 infection and block IFNs’ 
function; on the other hand, the interleukin-1α is released from the host cell, and that 
plays role in recruiting leucocytes to the site of infection by expressing the IL-1 
receptor type 1(IL-1R1) which is the same in both the epithelial cells and 
macrophages 30-35. Therefore, we attribute the increase of cell viability and the 
decrease of virus titers at 24 hours in co-culture to the stimulus which could be IL-1α.    
However, the cell viability was significantly decreased in the PAM-212 and 
macrophages monolayer, and the co-culture model infected with HSV-1at 48 hours 
post-infection. There was no significant difference in cell viability between the 
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infected groups in RAW 264.7 and PAM-212 at 48 hours post-infection compared to 
the co-culture (Figure 11). We think that the decrease in macrophage cell viability 
due to the increase of pro-inflammatory cytokines production such as TNF-α which is 
known by its cytotoxicity to the cells, but it plays role in immune response against 
invaders. Also, in the co-culture model was decreased in cell viability due to the 
duration of exposure to the virus. 
In the plaque assay result at 48 hours post the HSV-1 infection, the 
macrophages monolayer showed a sharp decrease in the virus titers compared to the 
keratinocytes which increase the virion concentration that counted on the plaque 
forming units per ml. Our results suggest that the macrophages monolayer was able to 
induce an immune response and restrict the HSV-1 replication during the incubation 
period of 48 hours compared to 24 hours (~ 4.9 fold, P-value = <0.001) (Figure 14).  
In contrast, the keratinocyte monolayer and co-culture exhibited a significant increase 
in the virus progeny (~1.65X106 fold, 1.11X106 fold, P-value = 0.008, P-value = 
0.012) respectively (Figure 17).  
Our experiment outcomes show a significant decrease the cell viability in the 
PAM-212 and macrophages monolayer, and the co-culture model infected with HSV-
1at 72 hours post-infection, but however, there was no significant difference in cell 
viability between the infected groups in RAW 264.7 and PAM-212 at 72 hours post-
infection compared to the co-culture (Figure 11). We think that the decrease in cell 
viability in all cell line models due to many factors includes the increase of cytokines 
cytotoxicity, the increase in virus titers, the duration of exposure, and/or macrophages 
depletion especially in the co-culture model.   
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Finally, we have noticed in the plaque assay results that the macrophages were 
unable to withstand with the virus replication at 72 hours. That may be due to the 
increase of pro-inflammatory cytokines level such as TNF-α which is known by its 
cytotoxicity to the cells as a response to the infection. Therefore, the macrophages 
were depleted, and their function was impaired that permitted the virus dissemination.  
However, in our results of the macrophages still show a decrease in the virus titers 
compared to the keratinocytes monolayer and there was no significant difference 
between the virus concentration in the macrophages and the co-culture at 72 hours 

















In a real-life situation, macrophages along with other innate immune cells would 
should restrict HSV-1 invasion by induction of antiviral response. This in vitro co-culture 
study system does not permit infiltration of immune cells such as neutrophils, dendritic 
cells (DC), and macrophages, a limitation of the study. Further studies in understanding 
the immune response of macrophages (RAW 264.7) to HSV-1 infected keratinocytes 
(PAM-212) would include identification of the cytokines and other molecules involved, 
especially IFN-α/β, TNF-α, IL1-α/β, IL- 10, and ROS. In addition, this co-culture model 
could be altered to simulate the effect of macrophages infiltration by adding additional 
macrophages at ratio 1:5 or 2:5 (macrophages to keratinocytes) two hours after initiating 
co-culture. Another way to alter the co-culture system is to enhance virus clearance by 
adding M1 macrophages at 2 hours after initiation of co-culture; this should enhance the 
anti-viral effect of IFN-β and other ant-viral macrophage products in the system. 
 The results from this co-culture system showed a significant increase in cell viability 
and a noticeable decrease in HSV-1 titers at 24 hours suggest a role of IL-1α and early 
production of IFN-β. Presumably, the IL-1α produced by the keratinocytes two hours 
after HSV-1 infection stimulates macrophages to produce IFN-β. Because IL-1α is 
produced by both macrophages and keratinocytes, blocking IL-1 receptor type 1(IL-1R) 
with specific antibody should interfere with production of antiviral IFN-β and allow 
greater virus production. Based on this conjecture, a mixture of IFN-β and IL-1α may be 







Figure 6: Cell Viability obtained by Trypan Blue Exclusion Test utilizing 
hemocytometer for Keratinocytes (PAM-212) after 24, 48, and 72 hours. 
Keratinocytes exhibited slightly significant decrease (~6.5%, P-value = 0.001) in cell 
viability following infection with HSV-1 compared to control at 24 hours. Also, a 
significant decrease in viability was observed in keratinocytes (~16.6%, P-value = < 0.001) 
following infection at 48 hours. However, after 72 hours of infection there was a great 
significant decrease in cell viability about (~46.7%, P-value = <0.001). By comparison to 
the different of all time-periods, there was no significant difference between in infected 
keratinocytes at 24 and 48 hours (P-value = 0.055). In contrast, keratinocytes infected with 
HSV-1 at 72 hours showed significant decrease in cell viability compared to 24 and 48 
hours (P-value = <0.001, P-value = <0.001) respectively. The mean illustrates the 
percentages of viable cells and error bars represent standard error ±. The statistics were 
obtained utilizing Sigma-Plot 12.0, One-way ANOVA was applied. Stars (*) indicate the 




   
      
 
Figure 7: Cell Viability obtained by Trypan Blue Exclusion Test utilizing 
hemocytometer for Macrophages (RAW 264.7) at 24, 48, and 72 hours. 
Macrophages showed no a statistically significant difference in cell viability at 24 post 
infection (~1%, P-value = 0.439). While at 48 and 72 hours following infection, macrophages 
exhibited a large significant decrease in cell viability (~8.1%, 46.3%, P-value = <0.001, P-
value = <0.001) respectively compared to control. In comparison to the different of time- 
periods, there was significant difference between infected macrophages at 24 and 48 hours 
(~5.3 %, P-value = 0.033). In contrast, macrophages infected with HSV-1 at 72 hours showed 
significant decrease in cell viability compared to 24 and 48 hours (~44.8%, ~39.5%, P-value 
= <0.001, P-value = <0.001) respectively. The mean illustrates the percentages of viable cells 
and error bars represent standard error ±. The statistics were obtained utilizing Sigma-Plot 
12.0, One-way ANOVA was applied. Stars (*) indicate the significance level, *, P ≤ 0.05, 













Figure 8: Cell Viability obtained by Trypan Blue Exclusion Test utilizing 
hemocytometer for Co-culture (RAW 264.7 PAM-212) at 24, 48, and 72 Hours post-
infection with HSV-1. 
In the co-culture model exhibited a slightly significant difference in cell viability at 24 post 
infection (~1% (*) P-value = 0.026). While at 48 and 72 hours following infection, co-
cultured cell lines exhibited a large significant decrease in cell viability (~36.3%, 64.6%, 
P-value = <0.001, P-value = <0.001) respectively compared to the control. However; in 
comparison to the different of time-points, there was a grate significant difference between 
in infected co-cultured cell lines at 24, 48 and 72 hours (P-value = <0.001, P-value = 
<0.001, and P-value = <0.001) respectively. The mean illustrates the percentages of viable 
cells and error bars represent standard error ±. The statistics were obtained utilizing Sigma-
Plot 12.0, One-way ANOVA was applied. Stars (*) indicate the significance level,*, p ≤ 





   
 
 
Figure 9: Cell Viability obtained by Trypan Blue Exclusion Test utilizing 
hemocytometer for (RAW 264.7, PAM-212, and Co-culture) at 24 Hours post-infection 
with HSV-1.  
The keratinocytes (PAM-212) monolayer exhibited a significant reduction in cell viability at 
24 post infection (~6.5%, P-value = 0.001). While the macrophages (RAW 264.7 /M0) 
monolayer showed no significant difference at 24 hours following infection. Whereas, the co-
cultured cell lines exhibited a little significant decrease in cell viability (~1%, P-value = 
0.026) compared to the control. However, in comparison between the co-cultured cell lines 
versus the different monolayers cell line, it showed a grate significant increase in cell viability 
at 24 hours (~7.7%, 7.5%; P-value = <0.001, P-value = <0.001) respectively.  While there was 
no significant difference between the keratinocytes and macrophages M0 monolayers (~ 
0.002%, P-value = 0.920). The mean illustrates the percentages of viable cells and error bars 
represent standard error ±. The statistics were obtained utilizing Sigma-Plot 12.0, One-way 
ANOVA was applied. Stars (*) indicate the significance level, *, P ≤ 0.05; **, P ≤ 0.01; ***, p 









Figure 10: Cell Viability obtained by Trypan Blue Exclusion Test utilizing hemocytometer 
for (RAW 264.7, PAM-212, and Co-culture) at 48 Hours post-infection with HSV-1.  
All monolayers and co-cultured cell lines (PAM-212, RAW 264.7/M0, and Co-culture) exhibited 
a significant decrease in cell viability at 48 post infection (~16.6%, 8.1%, & 36.3%; P-value = 
<0.001 P-value = <0.001, P-value = <0.001) respectively were compared to control. However; in 
comparison between the different of cell lines, there was no significant difference between the 
keratinocytes and macrophages M0 monolayers infected groups (~5.1 %,  P-value = 0.282) while 
the co-cultured cell lines infected group showed a grate significant decrease in cell viability at 48 
hours (~19 %, 24.1%; P-value = <0.001, P-value = <0.001) compared to (PAM-212 & RAW 
264.7/M0) respectively. The mean illustrates the percentages of viable cells and error bars 
represent standard error ±. The statistics were obtained utilizing Sigma-Plot 12.0, One-way 
ANOVA was applied. Stars (*) indicate the significance level, ***, p ≤ 0.001; ns = no 

















Figure 11: Cell Viability obtained by Trypan Blue Exclusion Test utilizing 
hemocytometer for (RAW 264.7, PAM-212, and Co-culture) at 72 Hours post-infection 
with HSV-1.  
All monolayers and co-cultured cell lines (PAM-212, RAW 264.7/M0, and Co-culture) 
exhibited a grate significant decrease in cell viability at 72 post infection (~46.7%, 46.3%, & 
64.6%; P-value = <0.001 P-value = <0.001, P-value = <0.001) respectively. However; in 
comparison between the different of cell lines, there was no significant difference between 
the keratinocytes and macrophages M0 monolayers infected groups (~6.1%, P-value = 0.323) 
while the co-cultured cell lines infected group showed a grate significant decrease in cell 
viability at 72 hours (~26.7 %, 20.6%; P-value = <0.001, P-value = 0.003) compared to 
(PAM-212 & RAW 264.7) respectively. The mean illustrates the percentages of viable cells 
and error bars represent standard error ±. The statistics were obtained utilizing Sigma-Plot 
12.0, One-way ANOVA was applied. Stars (*) indicate the significance level, **, P ≤ 0.01; 






Figure 12: Morphological Changes exhibited by Keratinocytes (PAM-212), Macrophages 
(RAW 264.7), Co-culture at Time-points of 24, 48, and 72 hours post-infection with HSV-
1.  The solid arrow exhibits the changes in morphology. The head’s arrows show floating cells. 
The dotted arrows show debris while the dotted circles illustrate the macrophages co-cultured 





Figure 13: The Plaque Assay for Keratinocytes (PAM-212) Infected with HSV-1 at 24, 
48, and 72 Hours. In keratinocytes (PAM-212) at 24 hours, plaques formation was observed 
from 10-1 to 10-5. However, the virus titers were counted at x10-3, and the plaque formed per 
ml (PFU/ml) was 12.6 X 10-3 in average. At 48 hours, plaques formation was observed from 
10-1 to 10-10. The virus titers were counted at x10-8, and the plaque formed per ml (PFU/ml) 
was 214 X 10-8 in average. While at 72 hours, plaques formation was observed from 10-1 to 
10-10. The virus titers were counted at x10-8, and the plaque formed per ml (PFU/ml) was 224 
X 10-8 in average. On the other hand, HSV-1 titers were significantly increased in the 
keratinocytes from 24 to 48 and 72 hours respectively. In contrast, there was no significant 
difference between virion replication at 48 and 72 hours. The mean illustrates virus titers and 
error bars represent standard error ±. The statistics were obtained utilizing Sigma-Plot 12.0, 
One-way ANOVA was applied. Stars (*) indicate the significance level, **, P ≤ 0.01; ***, p 
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Figure 14: The Plaque Assay for Macrophages (RAW264.7) Infected with HSV-1 at 24, 48, 
and 72 Hours. In macrophages (RAW 264.7/ M0) at 24 hours, plaques formation was observed 
from 10-1 to 10-5. However, the virus titers were counted at x10-3, and the plaque formed per ml 
(PFU/ml) was 65.6 X 10-3 in average. At 48 hours, plaques formation was only observed from 10-1 
to 10-5 and there were no plaques formation beyond the dilution factor x10-5 as was demonstrated 
by six trials. The virus titers were counted at x10-2, and the plaque formed per ml (PFU/ml) was 
132 X 10-2 in average. While at 72 hours, plaques formation was observed from 10-1 to 10-10. The 
virus titers were counted at x10-8, and the plaque formed per ml (PFU/ml) was 91 X 10-8 in 
average. Moreover, HSV-1 titers were remarkably decreased in the macrophages (M0) from 24 to 
48 hours. However, there was a large significant increase in virion titers at 72 hours compared to 
24 and 48 hours. The mean illustrates virus titers and error bars represent standard error ±. The 
statistics were obtained utilizing Sigma-Plot 12.0, One-way ANOVA was applied. Stars (*) 









Figure 15: The Plaque Assay for Co-culture (PAM-212 + M0) Infected with HSV-1 at 
24, 48, and 72 Hours. In co-culture model (PAM-212 + RAW 264.7/M0) at 24 hours, 
plaques formation was observed only at 10-1 in one plate while other plate did not show any 
plaques formation beyond the dilution factor x10-1 as was demonstrated by four trials. 
However, the virus titers were counted at x10-1, and the plaque formed per ml (PFU/ml) was 
55.3 X 10-1 in average. At 48 hours, plaques formation was observed from 10-1 to 10-10. The 
virus titers were counted at x10-8, and the plaque formed per ml (PFU/ml) was 34.6 X 10-8 in 
average. While at 72 hours, plaques formation was observed from 10-1 to 10-10. The virus 
titers were counted at x10-8, and the plaque formed per ml (PFU/ml) was 91.3 X 10-8 in 
average. However, HSV-1 titers were noticeably decreased in the co-culture model at 24 
compared to virus titers at 48 and 72 hours respectively. Nevertheless, there was a slightly 
difference between virion concentrations at 48 and 72 hours. The mean illustrates virus titers 
and error bars represent standard error ±. The statistics were obtained utilizing Sigma-Plot 
12.0, One-way ANOVA was applied. Stars (*) indicate the significance level, *, P ≤ 0.05; 








Figure 16: The Plaque Assay compared between all Cell Lines (RAW 264.7, PAM-212, 
and Co-culture) Infected with HSV-1 after 24 Hours. The keratinocytes (PAM-212) 
monolayer exhibited less significant in virus concentration compared with macrophages at 
24 hours (~5.1fold, P-value = <0.001). While the macrophages (RAW 264.7 /M0) 
monolayer showed the most significant increase in HSV-1 replication at 24 hours compared 
to 24 and 72 hours (~5.1 fold, 118 fold, P-value = <0.001, P-value = <0.001) respectively. 
On the other hand, the co-cultured cell lines (PAM-212 + RAW 264.7/M0) exhibited the 
lowest significant in virion titers compared to the monolayers infected groups at 24 hours 
(~22.7 fold, 118 fold, P-value = <0.001, P-value = <0.001) respectively. The mean 
illustrates virus titers and error bars represent standard error ±. The statistics were obtained 
utilizing Sigma-Plot 12.0, One-way ANOVA was applied. Stars (*) indicate the 







Figure 17: The Plaque Assay compared between all Cell Lines (RAW 264.7, PAM-212, 
and Co-culture) Infected with HSV-1 after 48 Hours. The keratinocytes (PAM-212) 
monolayer exhibited no significant in virus concentration compared with co-culture at 48 
hours (~1.5 fold, P-value = 0.078). While the macrophages (RAW 264.7 /M0) monolayer 
showed the lowest significant in HSV-1 replication at 48 hours compared to 24 and 72 hours 
(~1.65X106 fold, 1.11X106 fold, P-value = 0.008, P-value = 0.012) respectively. The mean 
illustrates virus titers and error bars represent standard error ±. The statistics were obtained 
utilizing Sigma-Plot 12.0, One-way ANOVA was applied. Stars (*) indicate the significance 









Figure 18: The Plaque Assay compared between all Cell Lines (RAW 264.7, PAM-212, 
and Co-culture) Infected with HSV-1 after 72 Hours. The keratinocytes (PAM-212) 
monolayer exhibited a significant increase in virus concentration compared with 
macrophages (M0) and co-culture at 72 hours (~5.6 fold, 2.44 fold, P-value = <0.001, P-
value = <0.001). While the macrophages (RAW 264.7 /M0) monolayer showed the less 
significant in HSV-1 replication at 72 hours compared to keratinocytes and co-culture (~5.6 
fold, 2.3 fold, P-value = <0.001, P-value = 0.052) respectively. The mean illustrates virus 
titers and error bars represent standard error ±. The statistics were obtained utilizing Sigma-
Plot 12.0, One-way ANOVA was applied. Stars (*) indicate the significance level, **, p ≤ 









Figure 19: This Line Graph illustrates and Summarizes the Plaque Assay compared 
between all Cell Lines (RAW 264.7, PAM-212, and Co-culture) Infected with HSV-1 
after 24, 48, and 72 Hours. The dark dotted line represents the keratinocytes (PAM-212), 
the gray dotted line represents the macrophages (M0), and the solid line represents the co-
culture. The mean illustrates virus titers and error bars represent standard error ±. The 
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Figure 20: Plaque Formation for Keratinocytes (PAM-212) after 24, 48, 72 hours 
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Figure 21: Plaque Formation for Macrophages (RAW 264.7) after 24, 48, 72 hours 
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